Rifampicin-resistant tuberculosis (RR-TB)

Rifampicin-resistant tuberculosis (RR-TB) is a form of tuberculosis (TB) caused by bacteria that no longer respond to rifampicin, a key medication used to treat TB. This resistance can develop when the bacteria mutate, often due to incomplete or incorrect treatment. RR-TB is more difficult to treat and requires longer, more complex drug regimens with alternative medicines. It poses a significant public health challenge because it can spread from person to person if not properly managed. Detecting and treating RR-TB promptly is essential to improve patient outcomes and prevent further drug resistance.